Skip to main content

New Enterprise Associates — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

643
Companies
$44.2B
Total invested
$68.8M
Avg. check
49
Industries
Health Care 9Artificial Intelligence (AI) 7Biotechnology 7Software 7Medical 4Therapeutics 4+43 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 49–72 of 643
Translucent AI
March 2026

Translucent AI develops an AI-powered financial platform tailored for healthcare operators.

Artificial Intelligence (AI) · New York$27.0M Series A
CRISPR Therapeutics
March 2026

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.

Biopharma · Cambridge$550.0M Post-IPO Debt
Nitra
March 2026

Nitra is overhauling the healthcare industry with radically efficient and transparent solutions - starting with spend management.

Financial Services · New York$115.0M Debt Financing
Korro Bio
March 2026

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

Biotechnology · Cambridge$85.0M Post-IPO Equity
Samaya AI
February 2026

Samaya AI specializes in developing AI research agents that streamline knowledge workflows.

Artificial Intelligence (AI) · LondonVenture - Series Unknown
Tulip Interfaces
January 2026

Tulip is a frontline operations platform designed to empower companies with AI-enabled, connected applications.

Analytics · Somerville$120.0M Series D
Recludix Pharma
January 2026

Recludix pharma is a developing platform to treat cancer patients.

Biotechnology · San DiegoUndisclosed
Monte Rosa Therapeutics
January 2026

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.

Biotechnology · Basel$300.0M Post-IPO Equity
Phathom Pharmaceuticals
January 2026

Phathom Pharmaceuticals is a biopharmaceutical company.

Biotechnology · Florham Park$130.0M Post-IPO Equity
Cohere Technologies
January 2026

Cohere is a software company focused on mobile technology.

Communications Infrastructure · San Jose$15.0M Venture - Series Unknown
Mejuri
January 2026

Mejuri is a direct to consumer fine jewelry brand that introduces handcrafted, everyday jewelry without the traditional retail markup.

Crowdsourcing · TorontoConvertible Note
Tailor
November 2025

Tailor is a no-code headless ERP platform helping retail businesses unify tools, marketplaces, and teams on one system.

Consulting · Tokyo$15.0M Series A
Chaos
November 2025

Chaos is a defense technology company that develops advanced sensing, detection, and communication technologies for the military sectors.

Aerospace · Los Angeles$510.0M Series D
Fabric8Labs
November 2025

Fabric8Labs is a machinery company that specializes in metal 3D printing.

3D Printing · La Jolla$50.0M Venture - Series Unknown
House Rx
November 2025

House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.

Health Care · San Francisco$55.0M Series B
Clio
November 2025

Clio provides cloud-based legal practice management software, helping law firms manage cases, billing, and client relationships.

Artificial Intelligence (AI) · Vancouver$500.0M Series G
Popai Health
November 2025

Popai Health uses care coordination calls to extract important insights.

Health Care · San Francisco$11.0M Seed
Spiras Health
October 2025

Spiras Health is an operator of a healthcare company intended to extend the care of a patient dealing with complex chronic illness.

Health Care · BrentwoodSeries B
Synthesia
October 2025

Synthesia is an AI video platform that enables users to create videos from text using advanced AI avatars and voiceovers.

Artificial Intelligence (AI) · London$200.0M Series E
Resilience
October 2025

Resilience is a biomanufacturing company that provides access to complex medicines and protects biopharmaceutical supply chains.

Biopharma · La Jolla$825.0M Debt Financing
CoreStory
October 2025

CoreStory provides a platform that helps enterprises understand their legacy code.

Artificial Intelligence (AI) · Berkeley$32.0M Series A
X4 Pharmaceuticals
October 2025

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

Biotechnology · Cambridge$155.3M Post-IPO Equity
Uniphore
October 2025

Uniphore is a business-software company that provides a secure AI platform that deploys agentic AI across every enterprise function.

Artificial Intelligence (AI) · Palo Alto$260.0M Series F
FiscalNote
October 2025

FiscalNote uses artificial intelligence and big data to deliver predictive analytics on government information to determine its impact.

Artificial Intelligence (AI) · Washington$25.8M Post-IPO Debt

Where New Enterprise Associates invests

Health Care9
Artificial Intelligence (AI)7
Biotechnology7
Software7
Medical4
Therapeutics4

About New Enterprise Associates's portfolio

How many companies has New Enterprise Associates invested in?▸

New Enterprise Associates has invested in 643 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does New Enterprise Associates invest in?▸

New Enterprise Associates's top investment sectors include Health Care, Artificial Intelligence (AI), Biotechnology, Software, Medical. The firm invests across 49 different industry categories.

What is New Enterprise Associates's largest investment?▸

Among tracked funding rounds, Resilience received $825.0M in a Debt Financing round. New Enterprise Associates's total known invested capital is $44.2B.

What is the average investment size for New Enterprise Associates?▸

New Enterprise Associates's average investment size is $68.8M across its portfolio of 643 companies.

What are New Enterprise Associates's most recent investments?▸

Recent New Enterprise Associates portfolio additions include Translucent AI, CRISPR Therapeutics, Nitra, Korro Bio, Samaya AI. These companies were founded in 2020 or later.

Reach the founders behind these 643 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →